Osteonecrosis is a bone condition that begins as an ischemic process and can progress to subchondral collapse and premature joint degeneration in untreated cases. Conventional treatments offer physical or symptomatic relief but do not address the underlying physiological deficiencies. Regenerative therapeutic techniques based on stem cells have been developed to stimulate osteogenesis, vascular therapeutic, and immunomodulation in bone defects. Existing clinical applications are based on mesench